Novartis reveals positive three-year efficacy data for psoriatic arthritis drug
November 15, 2016Manufacturing and Production, Research and Development Cosentyx, Novartis, psoriatic arthritis
Novartis has claimed that its Cosentyx (secukinumab) treatment is now the first approved fully human interleukin-17A (IL-17A) inhibitor to demonstrate …
Teva’s white elephant plant in Mexico inoperative
November 14, 2016Manufacturing and Production Mexico, Rimsa, Teva
The Teva-Rimsa debacle continues to rumble on, with Teva’s plant in Mexico not producing any drugs for market. The plant …
Allergan appoints Adriane M. Brown to board of directors
November 14, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan
Allergan announced that Adriana M. Brown will join its board of directors on February 2017. Adriana Brown is currently the …
Free Pharmacovigilance Webinar: Available to view now!
November 14, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance
Pharmafocus, alongside PrimeVigilance, hosted a webinar on 10 November and is now available to view for free.Throughout the webinar, PrimeVigilance …
Roche, Bayer and more speak out against German pricing cap plans
November 14, 2016Sales and Marketing Bayer, Germany, Roche
A number of major drug manufacturers have spoken out against German government plans to cap prescription drug pricing in the …
Mereo BioPharma appoint Richard Jones as CFO
November 14, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mereo BioPharma
Mereo BioPharma, a UK-based biopharmaceutical company, has announced that Richard CM Jones has been appointed chief financial officer of the …
Experimental Novartis leukaemia and mastocytosis drug gets FDA Priority Review
November 14, 2016Research and Development, Sales and Marketing FDA, Novartis, acute myeloid leukaemia
The US FDA has granted Priority Review status to Novartis’ experimental drug PKC412 (midostaurin) as a treatment for advanced systemic …
Pfizer’s Celebrex found to be safe on hearts after 10-year clinical study
November 14, 2016Medical Communications, Sales and Marketing Pfizer, celebrex, ibuprofen, naproxen
Pfizer’s drug, Celebrex, has been vindicated as of equivalent safety, or better, than ibuprofen and naproxen, after a 10-year study. …
GSK emerges top of the pile for improving access to medicine
November 14, 2016Medical Communications, Sales and Marketing Access to Medicine Index, GSK, market access, pricing
GlaxoSmithKline, the British drugmaker, has topped the overall ranking of the Access to Medicine Index, which ranks 20 top pharmaceutical …
Top Ten articles in the Pharma Industry this week
November 11, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing November, news, pharmaceutical, top 10, top ten, top ten stories
This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …
Almac Group announces £27 million global expansion
November 11, 2016Medical Communications, Sales and Marketing Almac Group, investment
Almac Group, a global contract pharmaceutical development and manufacturing organisation, has announced that it will spend £27 million in a …
Bionical adds Emas Pharma in strategic acquisition
November 11, 2016Medical Communications, Sales and Marketing Bionical, Emas pharma, acquistion
Bionical, an integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, has announced the acquisition of Emas Pharma. …
Alexion begins internal probe into sales practices
November 11, 2016Medical Communications Alexion, sales practices
Alexion Pharmaceuticals released a statement that it was to begin conducting an internal investigation into sales practices for Soliris (eculizumb) …
Proposition 61 defeated to allay changes on drug pricing
November 11, 2016Medical Communications Bernie Sanders, Drug pricing, Proposition 61, california
Another major piece of voting news emerged on 9 November, with Proposition 61 voted down by Californian residents, with the …
Former Roche CEO joins Arix Bioscience as senior independent director
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Arix Bioscience, a Britain-based healthcare and life science company, appointed Franz Humer as a senior independent director on 31 October. …
Court of Appeal rules that the NHS can legally fund HIV-prevention drug PrEP
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Court of Appeals, Gilead, NHS England, Truvada, high court
A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …
Social media and mobile apps: Bringing people and clinical trials together
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
In part one, we looked at the difficulty in recruiting and retaining patients for clinical trials, and how increased communication …
Pfizer’s breast cancer drug gets EU approval
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Novartis, Pfizer, ibrance
Pfizer is celebrating the approval by the European Union of its breast cancer drug Ibrance, following a positive recommendation from …
Novavax cuts works force by a third in struggle to restructure
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost cutting, Jobs, Novavax, losses
Novavax released the news that it would cut away 30% of its workforce alongside third quarter results that revenues were …
Chinese FDA releases “drug scanner” app
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Food and Drug Administration, app
The China Food and Drug Administration (CFDA) has released a new app earlier this week which enables users to download …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
